Organon reported a Q3 revenue of $1.6 billion, marking a 5% growth driven by a 6% rise in its women's health franchise and a 17% surge in biosimilars. The FDA extended the review period for ...

JERSEY CITY, N.J., March 08, 2025--Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced results from an analysis of the Phase 3 ADORING 3 open-label ...

Pharmaceutical company Organon (NYSE:OGN) will be reporting earnings tomorrow before market hours. Here’s what investors should know. Organon beat analysts’ revenue expectations by 1.1% last ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Thursday reported fourth-quarter net income of $109 million. On a per-share basis… ...